Onabotulinumtoxin-A: Previous Prophylactic Treatment Might Improve Subsequent Anti-CGRP Monoclonal Antibodies Response in Patients with Chronic Migraine

Onabotulinumtoxin-A: Previous Prophylactic Treatment Might Improve Subsequent Anti-CGRP Monoclonal Antibodies Response in Patients with Chronic Migraine

The aim of the present study was to evaluate whether previous preventive treatment with onabotulinumtoxin-A might influence subsequent clinical response following a switch to anti-CGRP monoclonal antibodies (mAbs). The present retrospective study was conducted at the Headache Centre—Neurology Clinic...

Full description

Bibliographic Details
Main Authors: Giulia Ceccardi, Francesca Schiano di Cola, Salvatore Caratozzolo, Michele Di Pasquale, Marco Bolchini, Alessandro Padovani, Renata Rao
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Toxins
Subjects:
migraine
chronic migraine
onabotulinumtoxin A
CGRP
anti-CGRP monoclonal antibodies
prevention
Online Access:https://www.mdpi.com/2072-6651/15/12/677

Internet

https://www.mdpi.com/2072-6651/15/12/677

Similar Items